RVL Pharmaceuticals plc Long-term Debt, Gross
RVL Pharmaceuticals plc had Long-term Debt, Gross of $70.70 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2023-08-14
- 2023-06-30: Long-term Debt, Gross $70.70M.
- 2023-03-31: Long-term Debt, Gross $70.70M.
- 2022-12-31: Long-term Debt, Gross $75.00M.
- 2022-09-30: Long-term Debt, Gross $75.00M.
| Period end | Long-term Debt, Gross | Long-term Debt, Gross as first filed |
|---|---|---|
| 2023-06-30 | $70.70M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $70.70M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $75.00M 10-K · filed 2023-03-20 | |
| 2022-09-30 | $75.00M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $55.00M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $55.00M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $55.00M 10-K · filed 2022-03-30 | |
| 2021-06-30 | $216.10M 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $221.40M 8-K · filed 2021-09-08 | $219.53M 10-K · filed 2021-03-30 |
| 2019-12-31 | $271.36M 10-K · filed 2020-03-19 | |
| 2018-12-31 | $273.13M 8-K · filed 2019-12-20 |